We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Advanced Technique Diagnoses Lyme Disease Early

By LabMedica International staff writers
Posted on 06 May 2013
Patients who contract Lyme disease need a quick diagnosis so that essential treatment can begin to avoid long-term complications.

The diagnostic process may be delayed if a physician does not recognize a skin rash caused by Lyme disease because it does not have the bull's-eye appearance that is best known to physicians and the public.

Scientists at University of Medicine and Dentistry of New Jersey (UMDNJ; Newark, NJ, USA) working with others, enrolled 14 patients in an ongoing prospective trial which includes an advanced diagnostic technique that employs a selective amplification of DNA from Borrelia burgdorferi, the spirochete that causes Lyme disease. More...
This technique uses electrospray ionization mass spectrometry and isothermal amplification. This is then followed by polymerase chain reaction (PCR) testing, all designed to detect even small numbers of multiple strains of the Lyme agent. The patients were all over 18 years of age and lived in suburban Baltimore (MD, USA), where Lyme disease is endemic.

Unlike existing methods used to diagnose Lyme disease, the novel experimental technique is able to detect evidence of B. burgdorferi early, even in cases where the bacterium is still at low levels in the bloodstream, and sooner than traditional antibody tests, which may require several weeks before becoming positive. It also is able to distinguish between new infections and prior exposure to B burgdorferi.
Of the patients analyzed, ten were identified by the experimental technique to have strong microbiologic evidence of Lyme disease although they had presented with skin lesions that differed markedly from the classic bull's-eye pattern. The authors noted that “This emphasis on target-like lesions may have inadvertently contributed to an under appreciation for atypical skin lesions caused by Lyme disease." PCR of skin biopsy samples may provide insight as to whether a negative blood PCR is the result of infection with a skin-restricted strain in patients in whom bacterial dissemination is not expected or a result of low copy number of B. burgdorferi in the blood sample.

Steven E, Schutzer, MD, the senior author of the study, said, “Doctors who see a rash in a patient who has been in an area where Lyme disease frequently occurs should be alert to the fact that the Lyme disease rash does not have to look like a bull's-eye, ring-within-a ring, known as erythema migrans. The rash may look different. Doctors should search carefully both for other signs that might suggest Lyme disease, such as flu-like symptoms, and equally for signs that may point towards other conditions. Early diagnosis of most diseases gives the best chance for a cure. This is especially true for Lyme disease." The report was published in the May 2013 issue of the journal Emerging Infectious Diseases.

Related Links:
University of Medicine and Dentistry of New Jersey


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Serological Pipet Controller
PIPETBOY GENIUS
New
Hemodynamic System Monitor
OptoMonitor
New
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: Pancreas cells (left) showing early stages of malignant cancer in brown and same cells stained blue (right) indicate they are Integrin β3 (ITGB3) positive (Photo courtesy of UC San Diego Health Sciences)

Gene Signature Could Serve as Early Warning System for Aggressive Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal forms of cancer, with early detection remaining a major challenge. Precancerous cells must overcome significant stress and... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.